Calavo Growers (CVGW)
(Delayed Data from NSDQ)
$28.53 USD
-0.45 (-1.55%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $29.56 +1.03 (3.61%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Income Statements
Fiscal Year end for Calavo Growers, Inc falls in the month of October .
All items in Millions except EPS data.
10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 | |
---|---|---|---|---|---|
Sales | 972 | 1,191 | 1,056 | 1,059 | 1,196 |
Cost Of Goods | 902 | 1,117 | 998 | 969 | 1,068 |
Gross Profit | 70 | 74 | 57 | 90 | 128 |
Selling & Adminstrative & Depr. & Amort Expenses | 70 | 68 | 67 | 58 | 57 |
Income After Depreciation & Amortization | 0 | 6 | -10 | 32 | 71 |
Non-Operating Income | 1 | -7 | 11 | -43 | -7 |
Interest Expense | 3 | 2 | 1 | 1 | 1 |
Pretax Income | -1 | -3 | 1 | -12 | 64 |
Income Taxes | 6 | 3 | 11 | -4 | 13 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | -1 | -1 | -2 | -6 | -14 |
Income From Cont. Operations | -8 | -7 | -12 | -14 | 37 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -8 | -6 | -12 | -14 | 37 |
Depreciation Footnote | 10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 18 | 23 | 8 | 48 | 85 |
Depreciation & Amortization (Cash Flow) | 17 | 17 | 18 | 16 | 14 |
Income After Depreciation & Amortization | 0 | 6 | -10 | 32 | 71 |
Earnings Per Share Data | 10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 |
---|---|---|---|---|---|
Average Shares | 17.75 | 17.66 | 17.62 | 17.56 | 17.59 |
Diluted EPS Before Non-Recurring Items | -0.01 | 0.50 | 0.35 | 1.57 | 3.02 |
Diluted Net EPS (GAAP) | -0.47 | -0.35 | -0.67 | -0.78 | 2.08 |
Fiscal Year end for Calavo Growers, Inc falls in the month of October .
All items in Millions except EPS data.
7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 | |
---|---|---|---|---|---|
Sales | 179.60 | 184.38 | 127.61 | 241.18 | 259.88 |
Cost Of Goods | 159.50 | 164.03 | 115.14 | 225.72 | 234.85 |
Gross Profit | 20.09 | 20.36 | 12.47 | 15.46 | 25.02 |
SG&A, R&D, and Dept/Amort Expenses | 10.74 | 13.22 | 13.85 | 16.03 | 16.64 |
Income After SG&A, R&D, and Dept/Amort Expenses | 9.35 | 7.14 | -1.38 | -0.57 | 8.38 |
Non-Operating Income | -4.02 | 0.52 | 0.20 | -0.55 | 0.23 |
Interest Expense | 0.83 | 0.96 | 0.82 | 1.01 | 0.79 |
Pretax Income | 4.50 | 6.69 | -2.00 | -1.52 | 7.82 |
Income Taxes | -1.44 | 0.39 | 0.57 | 5.92 | 0.62 |
Minority Interest | -0.03 | 0.04 | 0.01 | -0.01 | 0.08 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | -0.58 | 0.20 | 0.00 | -0.48 | -0.50 |
Income From Cont. Operations | 5.37 | 6.51 | -2.57 | -7.92 | 6.71 |
Extras & Discontinued Operations | -6.13 | -0.41 | -3.68 | 0.00 | 0.00 |
Net Income (GAAP) | -0.73 | 6.06 | -6.27 | -7.91 | 6.63 |
Earnings Per Share Data | 7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 |
---|---|---|---|---|---|
Average Shares | 17.84 | 17.87 | 17.80 | 17.77 | 17.86 |
Diluted EPS Before Non-Recurring Items | 0.57 | 0.50 | -0.01 | -0.33 | 0.41 |
Diluted Net EPS (GAAP) | -0.04 | 0.34 | -0.35 | -0.44 | 0.37 |